[1] [1] SUN X H, DAI Y, CHEN Y H, et al. Primary angle closure glaucoma: What we know and what we don't know[J]. Prog Retin Eye Res, 2017, 57: 26-45. DOI: 10.1016/j.preteyeres.2016.12.003.

[2] [2] QUIGLEY H A, BROMAN A T. The number of people with glaucoma worldwide in 2010 and 2020[J]. Br J Ophthalmol, 2006, 90(3): 262-267. DOI: 10.1136/bjo.2005.081224.

[3] [3] WEINREB R N, AUNG T, MEDEIROS F A. The pathophysiology and treatment of glaucoma: a review[J]. JAMA, 2014, 311(18): 1901-1911. DOI: 10.1001/jama.2014.3192.

[4] [4] JONAS J B, AUNG T, BOURNE R R, et al. Glaucoma[J]. Lancet, 2017, 390(10108): 2183-2193. DOI: 10.1016/s0140-6736(17)31469-1.

[6] [6] GEDDE S J, LIND J T, WRIGHT M M, et al. Primary open-angle glaucoma suspect preferred practice pattern®[J]. Ophthalmology, 2021, 128(1): 151-192. DOI: 10.1016/j.ophtha.2020.10.023.

[8] [8] GEDDE S J, CHEN P P, MUIR K W, et al. Primary angle-closure disease preferred practice pattern®[J]. Ophthalmology, 2021, 128(1): 30-70. DOI: 10.1016/j.ophtha.2020.10.021.

[9] [9] KONSTAS A G P, QUARANTA L, BOZKURT B, et al. 24-h efficacy of glaucoma treatment options[J]. Adv Ther, 2016, 33(4): 481-517. DOI: 10.1007/s12325-016-0302-0.

[13] [13] SHU Y H, WU J, LUONG T, et al. Topical medication adherence and visual field progression in open-angle glaucoma: analysis of a large US health care system[J]. J Glaucoma, 2021, 30(12): 1047-1055. DOI: 10.1097/ijg.0000000000001943.

[14] [14] PENG C, JIA H, HU J, et al. Characteristics and publication status of minimally invasive glaucoma surgery trials registered in ClinicalTrials.gov, 2007-2024: a cross-sectional study[J]. BMJ Open, 2025, 15(1): e095854. DOI: 10.1136/bmjopen-2024-095854.

[15] [15] GEDDE S J, VINOD K, WRIGHT M M, et al. Primary open-angle glaucoma preferred practice pattern®[J]. Ophthalmology, 2021, 128(1): 71-150. DOI: 10.1016/j.ophtha.2020.10.022.